• Danielle Jolla, United States says, "I love your online pharmacy Because of your quick shipping and reasonable prices."
  • Jill Barrella, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."
  • Eric Gonzales, United States says, "The website is very user friendly, there is a lot of variety and checking out was easy."
  • Albert Martinez, United States says, "Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."
  • Natalie Wallace, United States says, "I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy Visit to discuss on various diseases and conditions
    Follow us on Twitter
    You are here: Home > Pharmacy News | Health Articles/Tips > Aurobindo > September 08, 2009

      Aurobindo gets US, Swiss nod for two drugs

      Posted AtThehindubusinessline.com

      MUMBAI: Aurobindo Pharma on Thursday said it has received regulatory approval in the United States for making and marketing low-cost anti-infection drug Clindamycin Hydrochloride.

      Besides, the drug maker has also received the Swiss government's nod for the licence of Cefepime APL injection, used in the treatment of various diseases, including pneumonia and skin-related infections.

      The US Food and Drug Administration has given its final approval to the company for Clindamycin Hydrochloride Capsules in the strengths of 150 mg and 300 mg, Aurobindo Pharma said in a filing to the Bombay Stock Exchange (BSE).

      Clindamycin capsules are generic equivalent of Pharmacia & Upjohn Company's Cleocin Hydrochloride capsules. According to an estimate for the 12-months ending March 2009, the product has a market size of about $55 million.

      “The product will be launched shortly,” Aurobindo said. After this approval, the Indian firm now has a total 101 approvals from the US drug regulator, which includes 73 final approvals and 28 tentative.

      The Swiss regulatory approval for Cefepime injection is in the strengths of 1g and 2g. This is Aurobindo's second product approval from Swissmedic, the company said.

      September 08, 2009


      Share this Article!

    Back to top^